Processa Pharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for Processa Pharma (PCSA).

Price Target Range — 6 Quarters

Analyst Consensus — 2 Analysts

1Buy

1Hold

Consensus RatingSpeculative Buy# Analysts2Avg. Consensus PT$63Upside to Avg. PT+4180.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 2, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$2→$1
Jun 30, 2025	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$6→$2
Dec 5, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$6
Oct 3, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$6
Aug 20, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$6
Aug 19, 2024	HC Wainwright & Co.	Raghuram Selvaraju	PT Cut	Buy	$8→$6
Aug 1, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$8
Jun 12, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$8
May 13, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Maintained	Buy	$8
Apr 25, 2024	HC Wainwright & Co.	Raghuram Selvaraju	Initiate	Buy	$8
Mar 6, 2024	Benchmark	Robert Wasserman	Maintained	Speculative Buy	$4
Nov 17, 2023	Maxim Group	Naz Rahman	Downgrade	Buy→Hold	—

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Processa Pharmaceuticals, Lowers Price Target to $1

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Processa Pharmaceuticals (NASDAQ:PCSA) with a Buy and lowers the price target from $2 to $1.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Processa Pharmaceuticals, Lowers Price Target to $2

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Processa Pharmaceuticals (NASDAQ:PCSA) with a Buy and lowers the price target from $6 to $2.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Processa Pharma (NASDAQ:PCSA) with a Buy and maintains $6 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Processa Pharma (NASDAQ:PCSA) with a Buy and maintains $6 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Processa Pharma (NASDAQ:PCSA) with a Buy and maintains $6 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Processa Pharma, Lowers Price Target to $6

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Processa Pharma (NASDAQ:PCSA) with a Buy and lowers the price target from $8 to $6.

Benzinga Newsdesk

Processa Pharmaceuticals Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Processa Pharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Processa Pharmaceuticals, Lowers Price Target to $1

PRO
HC Wainwright & Co. Maintains Buy on Processa Pharmaceuticals, Lowers Price Target to $2

PRO
HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Processa Pharma, Lowers Price Target to $6

People Also Watch

People Also Watch

Processa Pharmaceuticals Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

Processa Pharma Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on Processa Pharmaceuticals, Lowers Price Target to $1

PROHC Wainwright & Co. Maintains Buy on Processa Pharmaceuticals, Lowers Price Target to $2

PROHC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

PROHC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

PROHC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

PROHC Wainwright & Co. Maintains Buy on Processa Pharma, Lowers Price Target to $6

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Maintains Buy on Processa Pharmaceuticals, Lowers Price Target to $1

PRO
HC Wainwright & Co. Maintains Buy on Processa Pharmaceuticals, Lowers Price Target to $2

PRO
HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $6 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Processa Pharma, Lowers Price Target to $6